B.Riley/FBR Upgrades Acasti Pharma (ACST) to Buy
Tweet Send to a Friend
B.Riley/FBR analyst Chad Mabry upgraded Acasti Pharma (NASDAQ: ACST) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
